OR14,84 Twelve months safety and efficacy of LB03002, a new prolonged release formulation of rhGH, as compared to daily rhGH therapy in treatment-naïve children with growth failure due to insufficient secretion of endogenous growth hormone (GHD)
Titel:
OR14,84 Twelve months safety and efficacy of LB03002, a new prolonged release formulation of rhGH, as compared to daily rhGH therapy in treatment-naïve children with growth failure due to insufficient secretion of endogenous growth hormone (GHD)
Auteur:
Saenger, P.H. Khadilkar, V. Radjuk, K.A. Bolshova, E. Khadgawat, R. El Kholy, M. Peterkova, V. Desai, M. Mericq, V. Savoy, C. Ji, H.-J. Zadik, Z. Kratzsch, J. Bidlingmaier, M.